Roquette Showcases Expanded Formulation Capabilities at AAPS 2025 PharmSci 360

Showcasing technical expertise with 14 poster presentations and four speaker sessions

Lower Gwynedd Township, Pa., USA, November 4, 2025 — Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will showcase its expanded portfolio of pharmaceutical solutions at booth #3335 at AAPS 2025 PharmSci 360 from November 9-12, 2025, in San Antonio, Texas.

Supported by 14 scientific poster presentations and four expert-led sessions, Roquette will highlight advancements in controlled release performance, hydroxypropyl beta-cyclodextrins, and sustainable formulation strategies, alongside a broad portfolio of innovative solutions designed to meet the evolving needs of pharmaceutical developers.

“After the successful acquisition of Qualicaps in 2023 and the addition of IFF Pharma Solutions in May this year, we’re looking forward to presenting Roquette’s next chapter and the depth of our advanced formulation capabilities for health and pharma to attendees of AAPS PharmSci 360,” said Benjamin Roscoe, Application Development and Innovation Leader for the Health & Pharma Solutions Business Group. “Through our expanded portfolio and scientific contributions—from sustainability-driven excipient innovation to novel delivery platforms—we’re demonstrating how Roquette continues to support the development of effective, high-performance solutions which address many of the industry’s most pressing needs and offer real value for manufacturers, healthcare providers and patients alike.”

Showcasing the Depth of Roquette’s Scientific Expertise

Through 14 cutting-edge posters and four presentations, Roquette will demonstrate how its expanded portfolio can support the formulation and manufacturing of a range of advanced drug delivery formats.

Poster highlights include:

  • “Improving Stability and Sustainability of an Auto-Oxidative Excipient, Polyethylene Oxide, with Foil-Lined Packaging.” Monday, Nov. 10, 12:30 – 1:30 p.m. CET. Jason Hunt, Global Strategic Marketing Manager, will reveal how a foil-lined pouch-in-a-box packaging system contributes to sustainability initiatives.
  • “Formulation of Acetaminophen Chewable Tablets Using Carrageenan.” Tuesday, Nov. 11, 11:30 a.m. – 12:30 p.m. CET. Nasrin Mahmoudi, Ph.D., Senior Lead Applications Scientist, will present the impact of carrageenan’s water gel strength on tablet properties.
  • “A Novel Plant-Based Orally Disintegrating Films Platform Using Hydroxypropyl β-Cyclodextrin for Pharmaceutical Product Development of Poorly Soluble Drugs.” Wednesday, Nov. 12, 11:30 a.m. – 12:30 p.m. CET. Mohammad Nammas, R&D Scientist, will showcase how hydroxypropyl β-cyclodextrin can help manufacturers tackle solubility issues.

Presentations at the 360 Stages include:

  • “Sustainability by Design: Excipient Innovation for Resource-Efficient Formulation.” Tuesday, Nov. 11, 2:00 – 3:00 p.m. CET on 360 Stage #2, presented by Lily Lin, Ph.D., Senior Applications Scientist.
  • “Next-Gen Coatings: Merging Sustainability with Superior Performance.” Tuesday, Nov. 11, 3:00 – 4:00 p.m. CET on 360 Stage #1, presented by Peter Freed, Ph.D., Head of Global Pharma Customer Technical Support.

Roquette to be Recognized at Exclusive Poster Collection

During a prestigious and exclusive special poster collection in Poster Forum #4, Tao Peng, Ph.D., Senior Biopharma Research Manager at Roquette, will present the poster, “High-Concentration Protein Formulations: Mechanistic Understanding of Hydroxypropyl-β-Cyclodextrins Mitigates Viscosity Challenges.” Only five posters were selected for this exclusive presentation at AAPS PharmSci 360. Dr Peng’s session takes place on Wednesday, Nov. 12, from 9:30 to 10:25 a.m.

To learn more about what to expect from Roquette at AAPS PharmSci 360 2025 or to schedule a meeting with an expert, visit here.

About Roquette

Roquette is a leading provider of plant-based ingredients, excipients and pharmaceutical solutions dedicated to enhancing the quality and convenience of essential products for consumers and patients worldwide.

Roquette employs more than 11,000 people globally, operating in more than 150 countries through more than 40 manufacturing sites and 20 R&D and innovation centers. The company achieved a turnover of €4.5 billion in 2024.

Harnessing natural resources like wheat, corn and cellulose, Roquette crafts high-performance ingredients and solutions used in everyday foods, oral medications, advanced biopharmaceuticals, and bio-based products.

Roquette is a family-owned company driven by a long-term vision and a constant commitment to innovation. For almost a century, Roquette has been empowering better living and building a sustainable future by offering the best of nature.

Discover more about Roquette here.